Pharmaceutical company GlaxoSmithKline investing in UK
Brexit isn’t putting GlaxoSmithKline off. The announcement that the pharmaceutical company are investing in their UK sites follows news that their second quarter profits increased – consumer healthcare and vaccines for example were up 7% and 11% respectively.
“It is testament to our skilled UK workforce and the country’s leading position in life sciences that we are making these investments in advanced manufacturing here. From their manufacture in the UK, many of these medicines will be sent to patients around the world.”